Company page

Newron Pharmaceuticals S.p.a.

Newron Pharmaceuticals S.p.a. is a public company traded on the Swiss market under the ticker NWRN. The company has a market capitalization of approximately 386.3 million Swiss francs. Newron focuses on developing innovative treatments for patients with neurological and psychiatric disorders.